1174 related articles for article (PubMed ID: 16029334)
1. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of minoxidil in chemotherapy-induced alopecia.
Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD
J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
[TBL] [Abstract][Full Text] [Related]
3. Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation.
Yun SJ; Kim SJ
Dermatology; 2007; 215(1):36-40. PubMed ID: 17587837
[TBL] [Abstract][Full Text] [Related]
4. Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study.
Kanti V; Nuwayhid R; Lindner J; Hillmann K; Stroux A; Bangemann N; Kleine-Tebbe A; Blume-Peytavi U; Garcia Bartels N
Br J Dermatol; 2014 Mar; 170(3):643-50. PubMed ID: 24641211
[TBL] [Abstract][Full Text] [Related]
5. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U
Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567
[TBL] [Abstract][Full Text] [Related]
6. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
van de Kerkhof PC
Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
[TBL] [Abstract][Full Text] [Related]
8. Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs.
Schilli MB; Paus R; Menrad A
J Invest Dermatol; 1998 Oct; 111(4):598-604. PubMed ID: 9764839
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method.
Rebora A; Guarrera M; Baldari M; Vecchio F
Arch Dermatol; 2005 Oct; 141(10):1243-5. PubMed ID: 16230561
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
[TBL] [Abstract][Full Text] [Related]
11. The hair root pattern after calcipotriol treatment for scalp psoriasis.
Kuijpers AL; van Baar HM; van Gasselt MW; van de Kerkhof PC
Acta Derm Venereol; 1995 Sep; 75(5):388-90. PubMed ID: 8615060
[TBL] [Abstract][Full Text] [Related]
12. Telogen effluvium after allergic contact dermatitis of the scalp.
Tosti A; Piraccini BM; van Neste DJ
Arch Dermatol; 2001 Feb; 137(2):187-90. PubMed ID: 11176691
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
14. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
[TBL] [Abstract][Full Text] [Related]
15. Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice.
Paus R; Schilli MB; Handjiski B; Menrad A; Henz BM; Plonka P
Cancer Res; 1996 Oct; 56(19):4438-43. PubMed ID: 8813138
[TBL] [Abstract][Full Text] [Related]
16. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
Maurer M; Handjiski B; Paus R
Am J Pathol; 1997 Apr; 150(4):1433-41. PubMed ID: 9094998
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic features of alopecia areata: a new look.
Whiting DA
Arch Dermatol; 2003 Dec; 139(12):1555-9. PubMed ID: 14676070
[TBL] [Abstract][Full Text] [Related]
19. [Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study (author's transl)].
Orfanos CE; Vogels L
Dermatologica; 1980; 161(2):124-32. PubMed ID: 7398983
[TBL] [Abstract][Full Text] [Related]
20. Anagen effluvium.
Kanwar AJ; Narang T
Indian J Dermatol Venereol Leprol; 2013; 79(5):604-12. PubMed ID: 23974578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
